A seminar discussing the roles and limitations that AI technology can play in the diagnosis and treatment of infectious diseases will be held on November 3 at 4:30 PM in Room 208 of the Jeonbuk National University (JBNU) Humanities and Social Sciences Building.
The seminar, organized by the Adaptive AI Lab led by Professor Cho Jae-hyeok, is drawing attention with Professor Lee Jae-gap (Department of Infectious Diseases, Hallym University Gangnam Sacred Heart Hospital), an authority on infectious diseases who earned public trust during COVID-19 response through expert and principled analysis, participating as the keynote presenter.
As field-specific applications of artificial intelligence (AI) have emerged as a key issue across industry and academia, this seminar was convened to explore strategies for domain-specific AI utilization, with a focus on the medical field.
In particular, as the importance of infectious disease response has been emphasized since the COVID-19 pandemic, building precision medicine and public health decision-support systems using AI has become a national priority. At JBNU, Professor Cho Jae-hyeok's team (Department of Software Engineering), which organized the seminar, is working with domestic experts including Professor Lee Jae-gap of Hallym University to develop AI systems for infectious disease response.
The seminar will be chaired by Professor Cho Jae-hyeok, an adaptive AI systems researcher and an expert who has led numerous medical AI research projects. He will guide the discussion, addressing key issues such as AI model reliability, data bias, and ethical validation.
Professor Lee Jae-gap, an authority in the field of infectious diseases, will deliver a presentation titled "The Use of AI in the Diagnosis and Treatment of Infectious Diseases." He will analyze the clinical characteristics and response systems for infectious diseases, as well as the practical roles AI can play in clinical settings, its application limits, and related ethical issues from a field-based perspective.
In addition, Professor Jang Hyung-eun of JBNU's Department of Nursing, Dr. Ko Ju-yeon from Yonsei University's Department of Preventive Medicine, and Director Lee Jun-wook of the AI company IveLab will participate to broadly discuss convergent research between medicine and AI and cooperative measures for public health.
Professor Cho Jae-hyeok said, "AI is a powerful tool that can increase the speed and accuracy of infectious disease response, but clinical practice is an area where process and responsibility are more important than outcomes." He added, "We will use this seminar as an opportunity to create a collaborative platform encompassing AI technology, medical ethics, and public health policy, and to strengthen JBNU's role as a hub for medical AI research."